Incanthera PLC Investor Presentation

RNS Number : 9341T

Incanthera PLC

26 June 2024

 

 

 

 

                                                                                26 June 2024

 

Incanthera plc

("Incanthera" the "Company")

Investor Presentation

 

Shares Investor Evening in Partnership with AJ Bell

 

Video Presentation live on Website

 

Incanthera plc (AQSE:INC), the company specially focussed on innovative technologies in dermatology and oncology, announces that, further to its recent presentation at Shares Investor Evening in partnership with AJ Bell, the video recording of the company's presentation is now live on the Company's website and can be accessed via the following link:

 

www.incanthera.com/news-media/press-coverage/ 

 

RNS Reach is a non-regulatory news service. By using this service an issuer is confirming that the information contained in this announcement is of a non-regulatory nature.

 

For further information please contact:

 

Incanthera plc www.incanthera.com   Tim McCarthy, Chairman [e-mail]   Simon Ward, Chief Executive Officer [e-mail]   Suzanne Brocks, Head of Communications [e-mail]	[phone]     [phone]     [phone]
Broker:  Stanford Capital Partners Ltd Patrick Claridge / Bob Pountney	[phone]/51

 

 

 

 

Notes to Editors

 

About Incanthera plc

 

Incanthera is a specialist company focused on innovative technologies in dermatology and oncology. It seeks to identify and develop innovative solutions to current clinical, commercially relevant unmet needs, utilising new technology from leading specialists and academic institutions as well as its in-house development team.

 

The Company originated from the Institute of Cancer Therapeutics ("ICT") at the University of Bradford.  Incanthera's strategy is to develop each candidate in its portfolio from initial acquisition or discovery to securing its future through commercially valuable partnerships at the earliest opportunity in its development pathway.

                                                                                                               

For more information on the Company please visit: www.incanthera.com

 

@incantheraplc

 

 

 

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

 

END

 

 

NRAQQLBLZQLEBBD